GetTopicDetailResponse(id=0bb61808075, topicName=UCP2, introduction=UCP2, content=null, image=null, comments=3, allHits=996, url=https://h5.medsci.cn/topic?id=18080, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=61998, tagList=[TagDto(tagId=61998, tagName=UCP2)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2044879, encodeId=266c20448e9ce, content=<a href='/topic/show?id=0bb61808075' target=_blank style='color:#2F92EE;'>#UCP2#</a>, objectTitle=Cell Death Dis：在缺血性腎損傷期間，UCP2誘導(dǎo)缺氧反應(yīng)促進(jìn)脂質(zhì)沉積和腎小管間質(zhì)纖維化, objectType=article, longId=188028, objectId=c2bb1880281d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2bb1880281d, replyNumber=0, likeNumber=91, createdTime=2020-02-16, rootId=0, userName=1249857fm32暫無昵稱, userId=ca282500032, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2bb1880281d, moduleTitle=Cell Death Dis：在缺血性腎損傷期間，UCP2誘導(dǎo)缺氧反應(yīng)促進(jìn)脂質(zhì)沉積和腎小管間質(zhì)纖維化, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c2bb1880281d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044878, encodeId=ba6420448e88e, content=<a href='/topic/show?id=0bb61808075' target=_blank style='color:#2F92EE;'>#UCP2#</a>, objectTitle=Free Radic Biol Med ：UCP2與Akt/mTOR通路聯(lián)合作用有作為胰腺腺癌治療的新型治療策略潛力, objectType=article, longId=117967, objectId=bdfc11e9676b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdfc11e9676b, replyNumber=0, likeNumber=71, createdTime=2018-07-17, rootId=0, userName=1249857fm32暫無昵稱, userId=ca282500032, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdfc11e9676b, moduleTitle=Free Radic Biol Med ：UCP2與Akt/mTOR通路聯(lián)合作用有作為胰腺腺癌治療的新型治療策略潛力, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=bdfc11e9676b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2044877, encodeId=96ad20448e7bb, content=<a href='/topic/show?id=0bb61808075' target=_blank style='color:#2F92EE;'>#UCP2#</a>, objectTitle=JCI：炎癥疾病治療新靶點(diǎn)--UCP2抑制劑有望治療敗血癥, objectType=article, longId=45364, objectId=988945364f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=988945364f6, replyNumber=0, likeNumber=94, createdTime=2015-02-27, rootId=0, userName=1249857fm32暫無昵稱, userId=ca282500032, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=988945364f6, moduleTitle=JCI：炎癥疾病治療新靶點(diǎn)--UCP2抑制劑有望治療敗血癥, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=988945364f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
